Tonghua Shenlong Pharmaceutical

Tonghua Shenlong Pharmaceutical is a Chinese pharmaceutical enterprise specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. Founded in 1989 and headquartered in Tonghua, Jilin Province, the company has built a robust portfolio focused on cardiovascular, cerebrovascular, and digestive health. Its flagship products include Xuesaitong capsules, which are widely used in China for improving blood circulation and treating ischemic conditions. The company operates multiple GMP-certified production lines and is listed on the National Equities Exchange and Quotations (NEEQ) in China. Tonghua Shenlong continues to integrate modern pharmaceutical technology with traditional herbal medicine to serve the domestic healthcare market.